FDA WARNING_LETTER - OHOM PADMAAVATHII LLC - January 06, 2026

On July 22, 2026, the FDA issued a warning letter to Ohom Padmaavathii, LLC, following an inspection conducted between December 2, 2025, and January 6, 2026, at their Dayton, New Jersey facility. This review followed several prior inspections between 2020 and 2022. The central issue identified is the company’s failure to develop and follow a Foreign Supplier Verification Program (FSVP) for its imported food products, specifically certain flour imports. Under the regulatory framework of the Federal Food, Drug, and Cosmetic Act, U.S. importers must perform risk-based activities to verify that foreign food suppliers meet domestic safety standards. Ohom Padmaavathii, LLC did not provide documentation showing they had established these mandatory safety protocols. The FDA previously issued a list of observations in January 2026, but the company failed to respond. To resolve this matter, the company must submit a written response within 15 working days detailing their corrective actions and providing evidence of a completed FSVP. Failure to comply may lead to severe consequences, such as the FDA refusing the entry of products into the country or placing imports on a "detention without physical examination" list. These requirements are intended to ensure that all imported food products are as safe as those produced within the United States.